TY - JOUR
KW - Community Mental Health Centers
KW - Community Mental Health Services/methods
KW - Comorbidity
KW - Delivery of Health Care, Integrated
KW - Diabetes Mellitus, Type 2/blood/epidemiology/therapy
KW - Feasibility Studies
KW - Female
KW - Glycated Hemoglobin A
KW - Humans
KW - intersectoral collaboration
KW - Male
KW - Middle Aged
KW - Outcome Assessment (Health Care)
KW - Patient Acceptance of Health Care
KW - Patient Care Team
KW - Pilot Projects
KW - Primary Health Care/methods
KW - Psychotic Disorders/epidemiology/therapy
KW - Schizophrenia/therapy
KW - Medical morbidity and mortality in psychiatric patients
KW - Research/service delivery integrated care
KW - collaborative care
AU - Lydia A. Chwastiak
AU - Mina Luongo
AU - Joan Russo
AU - Lisa Johnson
AU - Jessica M. Lowe
AU - Gail Hoffman
AU - Michael G. McDonell
AU - Brent Wisse
A1 - 
AB - OBJECTIVE: This study aimed to evaluate the feasibility, acceptability, and preliminary effectiveness (compared with usual care) of a collaborative care model to treat community mental health center (CMHC) patients with psychosis and poorly controlled diabetes. METHODS: Stakeholder input was used to adapt a primary care-based collaborative care intervention for CMHC settings. Thirty-five adult CMHC clients with type II diabetes and hemoglobin A1c (HbA1c) >8% or blood pressure >140/90 were randomized to receive either collaborative care or usual care. Change in HbA1c was evaluated between baseline and three months. Paired t tests were used for within-group comparisons. RESULTS: After three months, intervention participants had a statistically significant mean decrease in HbA1c of 1.1% (p=.049). There was no significant change in HbA1c in the usual-care group. CONCLUSIONS: This pilot demonstrates the feasibility and acceptability of implementing collaborative care in CMHC settings and its preliminary effectiveness in improving glycemic control in a high-risk population.
AD - Dr. Chwastiak, Dr. Russo, Ms. Lowe, and Ms. Hoffman are with the Department of Psychiatry and Behavioral Sciences, and Dr. Wisse is with the Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle. Ms. Luongo and Ms. Johnson are with the Harborview Medical Center, Seattle. Dr. McDonell is with the Addictions and Behavioral Health Innovations Department, Elson S. Floyd College of Medicine, Washington State University, Pullman.; Dr. Chwastiak, Dr. Russo, Ms. Lowe, and Ms. Hoffman are with the Department of Psychiatry and Behavioral Sciences, and Dr. Wisse is with the Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle. Ms. Luongo and Ms. Johnson are with the Harborview Medical Center, Seattle. Dr. McDonell is with the Addictions and Behavioral Health Innovations Department, Elson S. Floyd College of Medicine, Washington State University, Pullman.; Dr. Chwastiak, Dr. Russo, Ms. Lowe, and Ms. Hoffman are with the Department of Psychiatry and Behavioral Sciences, and Dr. Wisse is with the Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle. Ms. Luongo and Ms. Johnson are with the Harborview Medical Center, Seattle. Dr. McDonell is with the Addictions and Behavioral Health Innovations Department, Elson S. Floyd College of Medicine, Washington State University, Pullman.; Dr. Chwastiak, Dr. Russo, Ms. Lowe, and Ms. Hoffman are with the Department of Psychiatry and Behavioral Sciences, and Dr. Wisse is with the Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle. Ms. Luongo and Ms. Johnson are with the Harborview Medical Center, Seattle. Dr. McDonell is with the Addictions and Behavioral Health Innovations Department, Elson S. Floyd College of Medicine, Washington State University, Pullman.; Dr. Chwastiak, Dr. Russo, Ms. Lowe, and Ms. H(TRUNCATED)
BT - Psychiatric services (Washington, D.C.)
C5 - Education & Workforce; Healthcare Disparities
CP - 3
CY - United States
DO - 10.1176/appi.ps.201700153
IS - 3
JF - Psychiatric services (Washington, D.C.)
LA - eng
M1 - Journal Article
N2 - OBJECTIVE: This study aimed to evaluate the feasibility, acceptability, and preliminary effectiveness (compared with usual care) of a collaborative care model to treat community mental health center (CMHC) patients with psychosis and poorly controlled diabetes. METHODS: Stakeholder input was used to adapt a primary care-based collaborative care intervention for CMHC settings. Thirty-five adult CMHC clients with type II diabetes and hemoglobin A1c (HbA1c) >8% or blood pressure >140/90 were randomized to receive either collaborative care or usual care. Change in HbA1c was evaluated between baseline and three months. Paired t tests were used for within-group comparisons. RESULTS: After three months, intervention participants had a statistically significant mean decrease in HbA1c of 1.1% (p=.049). There was no significant change in HbA1c in the usual-care group. CONCLUSIONS: This pilot demonstrates the feasibility and acceptability of implementing collaborative care in CMHC settings and its preliminary effectiveness in improving glycemic control in a high-risk population.
PP - United States
PY - 2018
SN - 1557-9700; 1075-2730
SP - 349
EP - 352
EP - 
T1 - Use of a Mental Health Center Collaborative Care Team to Improve Diabetes Care and Outcomes for Patients With Psychosis
T2 - Psychiatric services (Washington, D.C.)
TI - Use of a Mental Health Center Collaborative Care Team to Improve Diabetes Care and Outcomes for Patients With Psychosis
U1 - Education & Workforce; Healthcare Disparities
U2 - 29191136
U3 - 10.1176/appi.ps.201700153
VL - 69
VO - 1557-9700; 1075-2730
Y1 - 2018
Y2 - Mar 1
ER -